摘要
目的:探讨金匮肾气丸对2型糖尿病胰岛素抵抗大鼠血糖(FBG)、血清胰岛素(FINS)及C肽(C-P)的影响。方法:40只SD大鼠采用高脂高糖饲料喂养3周,小剂量链脲佐菌素(STZ)腹腔注射诱导2型糖尿病胰岛素抵抗大鼠,随机分为模型组、二甲双胍组、肾气丸高剂量组、肾气丸低剂量组。另设正常组10只,饲以普通饲料。给药6周后处死大鼠,末次给药后禁食12h,检测FBG、FINS及C-P。结果:与正常组比较,模型组FBG、FINS水平明显增高(P<0.01);肾气丸能降低模型大鼠空腹FBG、FINS水平(P<0.05,P<0.01),提高血清C-P含量(P<0.05),并存在量效关系。结论:金匮肾气丸治疗糖尿病的机理可能与其具有改善胰岛β细胞的功能有关。
Objective:To study the effects of Jinkui Shenqi Pill on blood-glucose,serum insulin and C-peptide in rats with experimental type II diabetes.Methods: 40 SD rats were randomly divided into control group,metformin group,Shenqi Pill high dose group,Shenqi Pill low doses group after using high fat and sugar for 3 weeks and small dose Streptozotocin(STZ intraperitoneal injection) induced type Ⅱ diabetes rats with insulin resistance.A normal group of 10 with ordinary feeding.The rats were killed in the 6th week,blood-glucose,serum insul and C-peptide were detected.Results: Compared with normal group,control group had a significant higher level of blood-glucose and serum insulin(P〈0.01);Jinkui Shenqi pill could reduce the level of blood-glucose and sevum insulin in rat control group(P〈0.05,P〈0.01),and could improve the serum C-P content(P〈0.05),and there was a quantity-efficiency relation.Conclusion: The mechanism of Jinkui Shenqi Pill in the treatment of diabetes probably has a relationship with its function of improving the beta cell.
出处
《中医药学报》
CAS
2012年第2期25-27,共3页
Acta Chinese Medicine and Pharmacology
基金
湖南省卫生厅中医药专项基金(2008026)
湖南省教育厅(10C1054)
国家中医药管理局重点学科"方剂学"资助